These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25609961)

  • 1. PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway.
    Bao W; Liu R; Wang Y; Wang F; Xia G; Zhang H; Li X; Yin H; Chen B
    Int J Nanomedicine; 2015; 10():557-66. PubMed ID: 25609961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation.
    Bao W; Liu R; Xia G; Wang F; Chen B
    Drug Des Devel Ther; 2019; 13():1107-1115. PubMed ID: 31040647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted multidrug-resistance reversal in tumor based on PEG-PLL-PLGA polymer nano drug delivery system.
    Guo L; Zhang H; Wang F; Liu P; Wang Y; Xia G; Liu R; Li X; Yin H; Jiang H; Chen B
    Int J Nanomedicine; 2015; 10():4535-47. PubMed ID: 26213467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tf-PEG-PLL-PLGA nanoparticles enhanced chemosensitivity for hypoxia-responsive tumor cells.
    Liu P; Zhang H; Wu X; Guo L; Wang F; Xia G; Chen B; Yin H; Wang Y; Li X
    Onco Targets Ther; 2016; 9():5049-59. PubMed ID: 27574446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biocompatibility Assessment of Polyethylene Glycol-Poly L-Lysine-Poly Lactic-Co-Glycolic Acid Nanoparticles In Vitro and In Vivo.
    Guo L; Chen B; Liu R; Xia G; Wang Y; Li X; Wei C; Wang X; Jiang H
    J Nanosci Nanotechnol; 2015 May; 15(5):3710-9. PubMed ID: 26504996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Basic Research on Therapy of Leukemia with Nanoparticles Drug Delivery System Modified by Transferrin Receptor Monoclonal Antibody].
    Bao W; Liu R; Wang F; Nie C; Qian LB; Chen L; Wang Y; Chen BA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(4):939-944. PubMed ID: 37551459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daunorubicin-TiO2 nanocomposites as a "smart" pH-responsive drug delivery system.
    Zhang H; Wang C; Chen B; Wang X
    Int J Nanomedicine; 2012; 7():235-42. PubMed ID: 22275838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity.
    Yin P; Wang Y; Qiu Y; Hou L; Liu X; Qin J; Duan Y; Liu P; Qiu M; Li Q
    Int J Nanomedicine; 2012; 7():3961-9. PubMed ID: 22888239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional Polyethylene Glycol (PEG)-Poly (Lactic-Co-Glycolic Acid) (PLGA)-Based Nanoparticles Loading Doxorubicin and Tetrahydrocurcumin for Combined Chemoradiotherapy of Glioma.
    Zhang X; Zhao L; Zhai G; Ji J; Liu A
    Med Sci Monit; 2019 Dec; 25():9737-9751. PubMed ID: 31856143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
    Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
    Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
    Liu P; Yu H; Sun Y; Zhu M; Duan Y
    Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cRGD conjugated mPEG-PLGA-PLL nanoparticles for SGC-7901 gastric cancer cells-targeted Delivery of fluorouracil.
    Liu P; Wang H; Wang Q; Sun Y; Shen M; Zhu M; Wan Z; Duan Y
    J Nanosci Nanotechnol; 2012 Jun; 12(6):4467-71. PubMed ID: 22905486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional nanoplatform based on star-shaped copolymer for liver cancer targeting therapy.
    Gong X; Zheng Y; He G; Chen K; Zeng X; Chen Z
    Drug Deliv; 2019 Dec; 26(1):595-603. PubMed ID: 31195837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity and therapy of cisplatin-loaded EGF modified mPEG-PLGA-PLL nanoparticles for SKOV3 cancer in mice.
    Wang Y; Liu P; Qiu L; Sun Y; Zhu M; Gu L; Di W; Duan Y
    Biomaterials; 2013 May; 34(16):4068-4077. PubMed ID: 23480957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin.
    Wang J; Chen B; Cheng J; Cai X; Xia G; Liu R; Wang X
    Int J Nanomedicine; 2011; 6():1027-34. PubMed ID: 21720514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable tri-block copolymer poly(lactic acid)-poly(ethylene glycol)-poly(l-lysine)(PLA-PEG-PLL) as a non-viral vector to enhance gene transfection.
    Fu C; Sun X; Liu D; Chen Z; Lu Z; Zhang N
    Int J Mol Sci; 2011 Feb; 12(2):1371-88. PubMed ID: 21541064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slippery Nanoparticles as a Diffusion Platform for Mucin Producing Gastrointestinal Tumors.
    Khalili M; Zhou H; Thadi A; Daniels L; Fan Z; Morano WF; Ang J; Goldstein E; Polyak B; Mapow BC; Cheng H; Bowne WB
    Ann Surg Oncol; 2020 Jan; 27(1):76-84. PubMed ID: 31187366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells.
    Wang Q; Liu F; Wang L; Xie C; Wu P; Du S; Zhou S; Sun Z; Liu Q; Yu L; Liu B; Li R
    Int J Nanomedicine; 2020; 15():1283-1295. PubMed ID: 32161458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor.
    Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN
    Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.